Neurology
Migraine With Aura
15
Pipeline Programs↗
0
Active Trials↗
8
Companies Involved↗
Migraine With Aura is an emerging landscape with 15 programs across 8 companies. The most active players are AstraZeneca, GSK, Inflammx Therapeutics Inc. 7 therapies are approved.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical4
Phase 1
No programs
Phase 24
Phase 3
No programs
Analysis
Trial Status
5
clinical trials
Completed4 · 80%
Unknown status1 · 20%
Clinical Trials
Trial Activity
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)